Apriori Bio and A*STAR Infectious Diseases Labs Announce Strategic Partnership to Advance Next Generation Influenza Vaccines
https://www.europesays.com/ie/186747/
CAMBRIDGE, Mass. and SINGAPORE, Nov. 18, 2025 /PRNewswire/ — Apriori Bio, a Flagship Pioneering company focused on developing…